InvestorsHub Logo
Followers 82
Posts 2822
Boards Moderated 0
Alias Born 05/05/2006

Re: None

Sunday, 06/07/2009 5:47:04 AM

Sunday, June 07, 2009 5:47:04 AM

Post# of 3681
GNVC pancreatic cancer drug INCREASED SURVIVAL BY 8 MONTHS. For pancreatic that is a revolutionary result, $5 target. Compare Tarceva, which added 15 days to overall survival over 6 months.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.